Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citation:


Vashchenko N.V., Korobkova D.Z., Skorobogatykh K.V., Azimova Yu.E. Efficacy and safety of anti-CGRP(r) monoclonal antibodies in real clinical practice: preliminary analysis after three months of therapy. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):62-66. (In Russ.) https://doi.org/10.14412/2074-2711-2021-6-62-66

Views: 87


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)